Gastric Cancer · Nov 9, 2026

Global population-based prevalence of genetic carriers of CDH1-associated hereditary diffuse gastric cancer

By Prasitsumrit V, Paibulsirijit N, Charoenngam N

Background Hereditary diffuse gastric cancer (HDGC) is a rare autosomal dominant genetic disorder caused by loss-of-function mutations in the tumor suppressor gene CDH1. We aimed to estimate the carrier prevalence of HDGC-associated CDH1 variants across genetic ancestry groups using a large genomic database to identify potential disparities. Methods We conducted a population-based cross-sectional analysis of 807,162 unrelated individuals in gnomAD v4.1 across diverse genetic ancestry groups. CDH1 variants were identified using two approaches: (1) pathogenic or likely pathogenic (P/LP) variants classified by ClinVar or ClinGen, and (2) additional rare variants predicted to be deleterious in silico, including nonsense, frameshift, deleterious in-frame indels, splice-disrupting, and supported missense variants. Carrier frequency was estimated from combined allele frequencies and stratified by genetic ancestry. Result Among 3,381 CDH1 variants, 137 met study criteria. 47 were classified as P/LP by ClinVar or ClinGen, and 90 additional variants were predicted to be deleterious in silico. Using curated P/LP variants, the overall estimated carrier frequency was 8.67 per 100,000 individuals, with the highest ancestry-specific estimate in non-Finnish Europeans at 10.0 per 100,000. No carriers were observed in Ashkenazi Jewish, Finnish, or Middle Eastern groups. Inclusion of in silico–predicted variants increased the estimated carrier frequency to 44.1 per 100,000, with the highest estimate in the Middle Eastern group at 165.0 per 100,000. Conclusion HDGC-associated CDH1 variants may be more broadly distributed across populations than previously recognized. This genotype-first approach provides population-level carrier estimates independent of clinical ascertainment and highlights ancestry-related variation requiring further clinical and functional validation.

doi.org/10.1007/s10120-026-01823-xPubMed 43002353Populations

AgingResearch.News